Global Custom Market Research Reports Provider Company

phone

AstraZeneca KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 18
  • Category: Pharmaceuticals
  • Country: Japan
Summary

AstraZeneca KK (AstraZeneca), a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic diseases, respiratory and autoimmune diseases. AstraZeneca also offers treatment of EGFR T790M mutation positive for non-small cell lung cancer. The company has presence in Sapporo, Tokyo, Saitama, Osaka, Hiroshima and Fukuoka. It operates through its factory and distribution center located in Maibara and Ibaraki. AstraZeneca is headquartered in Osaka, Japan.

AstraZeneca KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AstraZeneca KK, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 11
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
Acquisition 13
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK - Key Competitors 15
AstraZeneca KK - Key Employees 16
AstraZeneca KK - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables

List of Tables
AstraZeneca KK, Pharmaceuticals & Healthcare, Key Facts 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Deals By Therapy Area, 2012 to YTD 2018 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 11
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK, Key Competitors 15
AstraZeneca KK, Key Employees 16
AstraZeneca KK, Other Locations 17

List Of Figures

List of Figures
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

General Data Protection Regulation (GDPR) in the Healthcare Industry: Implications for Healthcare - H1 2018 The EU voted to implement updated data protection laws in the form of the General Data

View Report

Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from

View Report

Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services. Pharmstandards product portfolio

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports